Correlation Between Dyadic International and Elicio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Elicio Therapeutics, you can compare the effects of market volatilities on Dyadic International and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Elicio Therapeutics.

Diversification Opportunities for Dyadic International and Elicio Therapeutics

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Dyadic and Elicio is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Dyadic International and Elicio Therapeutics

Given the investment horizon of 90 days Dyadic International is expected to generate 2.36 times less return on investment than Elicio Therapeutics. But when comparing it to its historical volatility, Dyadic International is 1.94 times less risky than Elicio Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  625.00  in Elicio Therapeutics on November 18, 2024 and sell it today you would earn a total of  192.00  from holding Elicio Therapeutics or generate 30.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dyadic International  vs.  Elicio Therapeutics

 Performance 
       Timeline  
Dyadic International 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dyadic International are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Dyadic International demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Elicio Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dyadic International and Elicio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyadic International and Elicio Therapeutics

The main advantage of trading using opposite Dyadic International and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.
The idea behind Dyadic International and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance